Società Italiana per lo Studio dell'Emostasi e della Trombosi

FRONTLINE2 is a global survey designed to evaluate how clinicians perceive the risk of venous thromboembolism in cancer patients and to provide insight into current strategies for thromboprophylaxis and management.
The survey’s aim is to bring together the views of oncologists, haematologists, surgeons, radiation oncologists and members of the palliative care team responsible for treating cancer-associated thrombosis (CAT). It will also describe the evolution of clinical understanding in this area since the first Frontline study in 2001, highlighting variations in care (nationally and internationally) and we hope that the survey will also generate new insights into this important clinical problem, helping resolve unanswered questions and encouraging the development of further research.
The value of this survey lies in achieving as large and as representative a sample of clinicians as possible to generate new insights into this important clinical problem, and to help resolve unanswered questions as well as potentially stimulating further research. Italy play a pivotal role in clinical research and it would be great if it plays the same role on FRONTLINE2. By giving a few minutes of your time to complete the questionnaire, you will provide crucial information to help meet these goals.
The value of this project lies in having as many participants as possible from round the globe and your continued support will help us reach this goal.
Here are the direct links to the website and the survey:
As a thank you for completing the survey, participants can download an educational slide set from our website. The goal of the slide series is to support the continued professional education in the field of venous thromboembolism and in particular cancer-associated thrombosis. In addition, all participants in the study will be granted first-hand access to the Frontline2 results once published.